-The Times of India NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the Department of Pharmaceuticals abruptly issued an order exempting such medicines from price control, derailing plans to make these drugs affordable. The health ministry discussed price capping and invoking compulsory licence for these “exorbitantly” priced “orphan drugs” at a meeting on January 3, the day when DoP...

-PTI NEW DELHI: The government on Thursday launched biodegradable sanitary napkins, priced at Rs 2.50 per pad, on the eve of International Women's Day, which will be available at Pradhan Mantri Bhartiya Janaushadhi Pariyojana Kendras. The sanitary napkins will be available in a pack of four pads for Rs 10 across over 3,200 Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Kendras by May 28, 2018, Minister of Chemicals and Fertilisers Ananth Kumar said...

-TheWire.in After huge incentives to corporate units, the Gujarat government is left with limited funds for education, health, environment and employment for the masses. What is the Gujarat model? In simple terms, it refers to a period from 2002-03 to 20011-12 during which Gujarat experienced a quantum jump in its growth rate. The driving force was the then chief minister Narendra Modi’s innovative interpretation of neoliberal policies. The growth strategy had three major...

-The Hindu Business Line Come November, the Jan Aushadhi initiative completes nine years. But despite its recent achievements, there's more work to be done. PT Jyothi Datta writes Earlier this year, Chemicals and Fertilizers Minister Ananth Kumar vowed to end the “medicine mafia” in the country by opening many more Jan Aushadhi kendras, stores that sell generic medicines at affordable prices. Kumar was echoing the mission outlined by Finance Minister Arun Jaitley...

-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...